Primary Diffuse Leptomeningeal Melanomatosis in an Indian Child With Review of Literature

• Published in: Pediatric neurology 2024-03, Vol.152, p.23-29
• Main Authors: Kumar, Ashna, Gunasekaran, Pradeep Kumar, Aggarwal, Divya, Janu, Vikas, Manjunathan, Sujatha, Laxmi, Veena, Tiwari, Sarbesh, Saini, Lokesh
• Format: Article
• Language: English
• Subjects: Brain - pathology; Child; Headache; Humans; Intracranial neoplasm; Leptomeningeal melanomatosis; Male; Malignant neoplasia; Melanoma - diagnosis; Melanoma - pathology; Melanoma - therapy; Meningeal Neoplasms - diagnostic imaging; Meningeal Neoplasms - therapy; Pediatrics; Primary diffuse leptomeningeal melanomatosis; Spinal Cord - pathology
• ISSN: 0887-8994; 1873-5150
• DOI: 10.1016/j.pediatrneurol.2023.12.007

Primary diffuse leptomeningeal melanomatosis (PDLM) is an extremely rare, aggressive malignant neoplasia of the central nervous system. We report the first case of pediatric PDLM from India. A review of literature was done to describe the 15 pediatric cases reported so far. A 12-year-old male child presented with fever, vomiting, and headache for 2 months. Cerebrospinal fluid examination was normal. An MRI of the brain revealed hydrocephalus, for which antitubercular therapy was started and external ventricular drainage followed by ventriculoperitoneal shunt was done. Repeat MRI revealed a suprasellar lesion, nodular enhancement of cranial nerves along with dural enhancement of spinal cord with arachnoiditis, and long-segment myelomalacia. Repeat cerebrospinal fluid examination was negative for malignant cells. During biopsy, blackish dura with diffuse blackish deposits in ventricle were noted. Histopathological examination revealed tumor cells with intracytoplasmic coarse brown pigment melanoma, frequent mitotic figures, and immunohistochemistry testing was positive for human melanoma black-45 and MelanA, suggestive of PDLM. He expired 4 months after the diagnosis. Diagnosing PDLM can be daunting in light of its slow but malignant progression mimicking TBM leading to improper management. However, the absence of any supportive microbiological evidence and failure to respond to the standard antitubercular therapy with subsequent progression of the symptoms should prompt the need for finding an alternative diagnosis. A targeted molecular diagnosis and precision medicine may provide a favorable outcome in children with PDLM.